ID: ALA5179453

Max Phase: Preclinical

Molecular Formula: C19H17N5O3

Molecular Weight: 363.38

Associated Items:

Representations

Canonical SMILES:  COc1ccc(N/C(N)=N/c2ncc(C(=O)c3ccccc3O)cn2)cc1

Standard InChI:  InChI=1S/C19H17N5O3/c1-27-14-8-6-13(7-9-14)23-18(20)24-19-21-10-12(11-22-19)17(26)15-4-2-3-5-16(15)25/h2-11,25H,1H3,(H3,20,21,22,23,24)

Standard InChI Key:  CTYWJEGNZBNUDY-UHFFFAOYSA-N

Associated Targets(Human)

Toll-like receptor 4 970 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 363.38Molecular Weight (Monoisotopic): 363.1331AlogP: 2.48#Rotatable Bonds: 5
Polar Surface Area: 122.72Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.12CX Basic pKa: 5.19CX LogP: 3.09CX LogD: 2.72
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.36Np Likeness Score: -0.66

References

1. Zhang Y, Liang X, Bao X, Xiao W, Chen G..  (2022)  Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective.,  235  [PMID:35307617] [10.1016/j.ejmech.2022.114291]

Source